Arena Scores Hefty Obesity Drug Deal With Eisai Ahead Of PDUFA Date

In addition to upfront and milestone payments, deal also includes effective royalties above 30 percent of annual net sales.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet